Clinical Trial Update: Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle [Phase 1]

View source ↗

Summary

Phase 1 study evaluating suppression of ovulation and pharmacokinetics of medroxyprogesterone acetate after TV-46046 in women with ovulatory cycles; completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Pregnancy

Drugs mentioned

• Medroxyprogesterone acetate (Medroxyprogesterone acetate)
• TV-46046

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Pregnancy, Contraception | Phase 1 | Status: COMPLETED | Results posted: 2024-02-12